Log inSign up
AAOIFI No. 21 screening

Is LTGO halal?

Latigo Biotherapeutics, Inc.

Doubtful

No clear verdict is possible for Latigo Biotherapeutics, Inc. — data is insufficient or the case is contested in fiqh. As a precaution it is NOT included in the halal list.

Checked: 14 October 2026

Exchange

NASDAQ

Price

14

Day

-5.15%

Market cap

$1.03B

Industry

Biotechnology

Sector

Healthcare

What the company does

Latigo Biotherapeutics (IPO 2026) develops non-opioid pain drugs (NaV1.8 inhibitors: LTG-001 for acute pain, LTG-321 for chronic, LTG-418) in clinical trials. No revenue.

What was checked

The AAOIFI standard has four steps: business activity first, then three financial ratios. Fail one and the stock is not halal.

  • Business activity

    No prohibited activity

  • Interest-bearing debt / market cap

    limit 30%

    Interest-bearing debt $29.90M ÷ current market cap $1.03B = 2.9%

    2.9%

    Pass

  • Cash & investments / market cap

    limit 30%

    Cash + interest-bearing securities $55.00M ÷ current market cap $1.03B = 5.3%

    5.3%

    Pass

  • Non-compliant income / total revenue

    limit 5%

    —

    No data

Figures from the company's filings (2026-06-30), USD. Market cap is a 36-month average (the S&P Shariah index approach), so a one-day price move does not flip the verdict.

In the lists

In the S&P 500
Not in the S&P 500

Halal stocks in the same industry

The largest halal stocks in Biotechnology — for comparison.

Related articles

Halal is the first question. The second: when to enter?

Our scanner watches 1454 halal stocks around the clock and fires a signal with entry, TP and SL when a technical setup completes. The full signal history — with outcomes — is public.

This is neither investment advice nor a fatwa. Screening is based on public financial statements and AAOIFI standard No. 21; data may lag. For a personal decision consult your own scholar.